Admission Date:  [**2121-12-1**]              Discharge Date:   [**2121-12-8**]  Date of Birth:  [**2066-12-15**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Ciprofloxacin / Benzodiazepines  Attending:[**Male First Name (un) 5282**] Chief Complaint: Altered Mental Status  Major Surgical or Invasive Procedure: 1.
Of note patient recently admitted and D/Ced for AMS, at that time no etiology could be found but patient improved with lactulose.
Durring last admit patient started on cefpodoxime for SBP proph.
The patient was given 2mg of ativan for agitation after which she became minimally responsive.
Denies chest pain, chest pressure, palpitations, or weakness.
Past Medical History: Hep C cirrhosis c/b ascites and encephalopathy, known grade I varices last EGD in [**3-/2120**], active on [**Year (4 digits) **] list ESRD on HD started [**5-/2121**] schedule MWF Cerebral Infarction - multifocal, thought to be embolic [**5-/2121**] Patent foramen ovale - open, not repairable per cards Diabetes on Insulin Hypertension Mitral Regurgitation (2+) S/p [**Year (4 digits) 105777**] [**Year (4 digits) 32050**] hernia repair [**5-11**] by Dr. [**Last Name (STitle) **] H/o sub-segmental PE in [**5-/2121**] not on anticoagulation  Social History: Worked as staff accountant at Sound life financial.
Pertinent Results: Labs on Admission: [**2121-12-1**] 11:08PM   TYPE-ART TEMP-35.7 PO2-108* PCO2-34* PH-7.53* TOTAL CO2-29 BASE XS-6 [**2121-12-1**] 07:00PM ASCITES  WBC-155* RBC-216* POLYS-0 LYMPHS-4* MONOS-12* MACROPHAG-84* [**2121-12-1**] 03:20PM   GLUCOSE-151* UREA N-27* CREAT-7.4*# SODIUM-136 POTASSIUM-4.7 CHLORIDE-100 TOTAL CO2-27 ANION GAP-14 [**2121-12-1**] 03:20PM   estGFR-Using this [**2121-12-1**] 03:20PM URINE  HOURS-RANDOM [**2121-12-1**] 03:20PM URINE  GR HOLD-HOLD [**2121-12-1**] 03:20PM   PT-18.5* PTT-40.2* INR(PT)-1.7* [**2121-12-1**] 03:20PM URINE  COLOR-Amber APPEAR-Clear SP [**Last Name (un) 155**]-1.016 [**2121-12-1**] 03:20PM URINE  BLOOD-SM NITRITE-NEG PROTEIN-75 GLUCOSE-NEG KETONE-15 BILIRUBIN-SM UROBILNGN-1 PH-5.0 LEUK-TR [**2121-12-1**] 03:20PM URINE  RBC-[**1-23**]* WBC-[**10-10**]* BACTERIA-FEW YEAST-NONE EPI-[**10-10**] TRANS EPI-0-2 RENAL EPI-0-2 [**2121-12-1**] 03:20PM URINE  WBCCLUMP-MANY [**2121-12-1**] 02:45PM   GLUCOSE-162* LACTATE-1.9 NA+-137 K+-4.8 CL--95* TCO2-29 [**2121-12-1**] 02:45PM   WBC-4.4 RBC-3.39*# HGB-10.6*# HCT-34.7*# MCV-102* MCH-31.2 MCHC-30.5* RDW-17.5* [**2121-12-1**] 02:45PM   NEUTS-64.5 LYMPHS-21.4 MONOS-11.2* EOS-1.4 BASOS-1.5 [**2121-12-1**] 02:30PM   AMMONIA-158* [**2121-12-1**] 12:18PM   CREAT-6.9*# SODIUM-132* POTASSIUM-5.0 CHLORIDE-96 [**2121-12-1**] 12:18PM   estGFR-Using this [**2121-12-1**] 12:18PM   TOT BILI-4.2* [**2121-12-1**] 12:18PM   ALBUMIN-2.5* [**2121-12-1**] 12:18PM   PT-18.6* INR(PT)-1.7*  Labs on Discharge: [**2121-12-8**] 07:00AM BLOOD WBC-5.7 RBC-2.56* Hgb-8.1* Hct-26.9* MCV-105* MCH-31.8 MCHC-30.2* RDW-18.0* Plt Ct-45* [**2121-12-8**] 07:00AM BLOOD PT-21.8* PTT-49.3* INR(PT)-2.0* [**2121-12-8**] 07:00AM BLOOD Glucose-161* UreaN-23* Creat-6.6*# Na-135 K-4.5 Cl-100 HCO3-27 AnGap-13 [**2121-12-8**] 07:00AM BLOOD ALT-17 AST-45* AlkPhos-155* TotBili-3.9* [**2121-12-8**] 07:00AM BLOOD Calcium-9.4 Phos-4.4 Mg-1.9  Micro:  Studies:  [**2121-12-1**] ECG - Sinus rhythm.
Borderline Q-T interval prolongation.
Nasogastric tube ends in the stomach.
A right central venous catheter ends in the right atrium, unchanged from the previous study.
Resting hemodynamics revealed normal right sided filling pressures with RVEDP 13mmHg and mildly elevated pulmonary capillary wedge pressure with PCWP 14mmHg.
A dual-channel right-sided central venous line ends close to the anticipated location of the tricuspid valve.
Brief Hospital Course: MICU COURSE:  [**12-1**] - Episode of hypertension to 190/82 overnight treated with an extra home dose Nadolol - Obtained ABG due to concern regarding tachypnea although saturating well, 7.53/34/108/29 BaseXS .
- Reduced lactulose from 45 mg q6 to q8 given loose stool.
She was continued on her home medications and lactulose was titrated to [**1-22**] BM daily.
She tolerated the procedure well.
Patient was treated with ceftriaxone for a possible UTI, but culture showed no growth, so this medication was discontinued.
The patient was continued on hemodialysis per renal consult team throughout this admission.
She considered this degree of ascites consistent with her baseline and had no pain or shortness of breath so therapeutic tap was deferred.
Patient was maintained on an insulin sliding scale.
# FEN: No IVF, replete electrolytes, regular diet # Prophylaxis: Pneumoboots # Access: PIVs # Communication: Patient, husband [**Name (NI) 9261**] # [**Name2 (NI) 7092**]:  Full  Medications on Admission: Lactulose 30ml PO QID titrate to [**1-22**] BMs daily Lansoprazole 30mg PO daily Rifaximin 400mg PO TID Cefpodoxime 200mg PO QHD Insulin SS Aranesp 300mcg/ml with HD B-complex vitamins 1capsule PO daily Caltrate 600mg (1500mg) PO daily Ferrous sulfate 325mg (65mg Iron) PO TID Nephplex Rx 1-60-300-12.5 mg-mg-mcg-mg Tablet PO daily Miconazole nitrate 2% cream topical daily Nadolol 20mg PO daily   Discharge Medications: 1.
Lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily).
Lactulose 10 gram/15 mL Syrup [**Last Name (STitle) **]: 15-30 MLs PO three times a day: Increase dose until you are having at least 3 bowel movements a day.
Rifaximin 200 mg Tablet [**Last Name (STitle) **]: Two (2) Tablet PO TID (3 times a day).
Cefpodoxime 100 mg Tablet [**Last Name (STitle) **]: Two (2) Tablet PO QHD (each hemodialysis).
Caltrate 600 600 mg (1,500 mg) Tablet [**Last Name (STitle) **]: One (1) Tablet PO once a day.
Ferrous Sulfate 325 mg (65 mg Iron) Tablet [**Last Name (STitle) **]: One (1) Tablet PO TID (3 times a day).
Nephplex Rx 1-60-300-12.5 mg-mg-mcg-mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO once a day.
Miconazole Nitrate 2 % Cream [**Last Name (STitle) **]: One (1) application Topical once a day: Apply to affected area.
Insulin Please continue your insulin sliding scale according to your home regimen.
Nadolol 20 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO DAILY (Daily).
Discharge Disposition: Home With Service  Facility: [**Company 1519**]  Discharge Diagnosis: Primary: - Hepatic encephalopathy - Cirrhosis of the liver secondary to hepatitis C virus  Secondary: - Diabetes mellitus type II - End stage renal disease, on hemodialysis   Discharge Condition: Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - requires assistance or aid (walker or cane)   Discharge Instructions: You were admitted to [**Hospital1 69**] with confusion.
You were unable to take medication by mouth, so you were admitted to the medical intensive care unit and a feeding tube was placed.
You tolerated this procedure very well.
The following day, your feeding tube was removed and you were able to walk with physical therapy.
We have made no changes to your medication regimen.
